Status:
UNKNOWN
A Prospective Randomized Multi-center Study for Efficacy of Metallic Biliary Stent Compared to Plastic Stent in Patients Receiving Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Lead Sponsor:
Yonsei University
Conditions:
Resectable Pancreatic Cancer With Biliary Obstruction
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Pancreatic cancer is the eighth most common occurrence in Korea. In the United States, pancreatic cancer is expected to be the number two cause of death from cancer in 2030. The prevalence of pancreat...
Eligibility Criteria
Inclusion
- Patients aged 20 years or older who have confirmed histologically or radiologically resectable pancreatic cancer
- Patients with clinical obstruction symptoms and radiographically confirmed biliary obstruction related to malignant tumors
- Patients receiving neoadjuvant chemotherapy before surgery
Exclusion
- Patients diagnosed as unresectable pancreatic cancer
- Patients with biliary obstruction due to biliary cancer, not pancreatic cancer
- Patients with duodenal obstruction
- Patients with pancreatic cance and other cancers
- Patients with severe uncontrolled infection
- Patients with 3 or higher of performance score as the Eastern Cooperative Oncology Group
- Patients who have not agreed with the informed consent
- Patients who are technically unable to be undergone endoscopic procedures
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT04911647
Start Date
June 1 2021
End Date
June 1 2023
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital, Yonsei University Health System
Seoul, South Korea